This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Markus Waldhuber
Introduction
Markus Waldhuber is a notable inventor recognized for his contributions in the field of biotechnology. He is currently associated with Novartis AG, a leading global healthcare company. His work primarily focuses on developing innovative solutions that address critical health challenges.
Latest Patents
Markus Waldhuber holds a patent for TREM2 Stabilizing Antibodies. This invention is significant in the realm of medical research and has the potential to impact therapeutic approaches for various diseases.
Career Highlights
Throughout his career, Markus has demonstrated a commitment to advancing scientific knowledge and improving patient outcomes. His work at Novartis AG has positioned him as a key player in the development of groundbreaking therapies.
Collaborations
Markus collaborates with talented professionals, including his coworker Dominik Feuerbach, to drive innovation and enhance research efforts within the company.
Conclusion
Markus Waldhuber's contributions to the field of biotechnology, particularly through his patent on TREM2 Stabilizing Antibodies, highlight his role as an influential inventor. His ongoing work at Novartis AG continues to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile